Trial · NCT01702571
Adverse events680
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 680
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Trastuzumab Emtansine (All Participants) | 173 | 2,002 | 231 |
| other | ANAEMIA | Blood and lymphatic system disorders | Trastuzumab Emtansine (Asian Participants) | 27 | 181 | 49 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Trastuzumab Emtansine (All Participants) | 19 | 2,002 | 23 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Trastuzumab Emtansine (Asian Participants) | 15 | 181 | 69 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Trastuzumab Emtansine (All Participants) | 79 | 2,002 | 151 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Trastuzumab Emtansine (Asian Participants) | 17 | 181 | 72 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Trastuzumab Emtansine (All Participants) | 165 | 2,002 | 257 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Trastuzumab Emtansine (Asian Participants) | 47 | 181 | 157 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Trastuzumab Emtansine (All Participants) | 139 | 2,002 | 182 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Trastuzumab Emtansine (Asian Participants) | 6 | 181 | 8 |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Trastuzumab Emtansine (All Participants) | 135 | 2,002 | 163 |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Trastuzumab Emtansine (Asian Participants) | 5 | 181 | 5 |
| other | CONSTIPATION | Gastrointestinal disorders | Trastuzumab Emtansine (All Participants) | 394 | 2,002 | 568 |
| other | CONSTIPATION | Gastrointestinal disorders | Trastuzumab Emtansine (Asian Participants) | 10 | 181 | 38 |
| other | DIARRHOEA | Gastrointestinal disorders | Trastuzumab Emtansine (All Participants) | 252 | 2,002 | 376 |
| other | DIARRHOEA | Gastrointestinal disorders | Trastuzumab Emtansine (Asian Participants) | 9 | 181 | 9 |
| other | DRY MOUTH | Gastrointestinal disorders | Trastuzumab Emtansine (All Participants) | 283 | 2,002 | 303 |
| other | DRY MOUTH | Gastrointestinal disorders | Trastuzumab Emtansine (Asian Participants) | 7 | 181 | 13 |
| other | GINGIVAL BLEEDING | Gastrointestinal disorders | Trastuzumab Emtansine (All Participants) | 83 | 2,002 | 96 |
| other | GINGIVAL BLEEDING | Gastrointestinal disorders | Trastuzumab Emtansine (Asian Participants) | 14 | 181 | 19 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01702571/events